AlphAIAlphAI — Financial news for AI agents
SEC EDGAR 8-K$NGVT

Ingevity reports third quarter 2026 financial results

Ingevity Corp (NGVT) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Ingevity Corporation 4920 O'Hear Avenue Suite 400 North Charleston, SC 29405 USA www.ingevity.com Ingevity reports third quarter 2026 financial results Third Quarter 2026 Results and Recent Highlights: • Net sales of $305.1 million decreased 8% from prior year; exclu

Original reporting
SEC EDGAR 8-K
Published Nov 4, 2026, 9:19 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 4, 2026, 9:24 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefEarnings
Primary signal
$NGVT
Neutral
high confidence
Mentioned
$NGVT
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$NGVTNeutralMed
01

Why it matters

The company posted mixed segment performance, with strong Performance Materials and Advanced Polymer Technologies offset by weaker Pavement Technologies. Guidance was narrowed but the midpoint remained unchanged, indicating a neutral outlook.

02

Market read

The earnings release provides fresh guidance for a mid‑cap specialty chemicals firm, offering traders a basis for short‑term positioning.

03

What to watch

Potential upside from the upcoming Advanced Polymer Technologies agreement in early 2027 is not reflected in current guidance.

Relevance 7/10Novelty 8/10Timing: immediate release today

Background

Ingevity Corp (NYSE: NGVT) filed an 8‑K reporting its Q3 2026 financial results, including sales, earnings, and updated full‑year EBITDA guidance.

Company-level read

Ticker impact

$NGVTNeutralHigh confidence
Context

Ingevity Corp reported Q3 2026 results and narrowed full-year adjusted EBITDA outlook to $385M-$395M, maintaining the prior midpoint.

Expected impact

likely modest pressure as the market prices in the narrowed outlook without a clear upside catalyst

Evidence & confidence

Guidance is updated but not raised; investors may view the maintained midpoint as a neutral signal, leading to limited price movement.

Market effects

Sector

Performance Materials and Advanced Polymer Technologies segments show resilience, which may benefit peers in specialty chemicals.

Regional

North American demand for filtration and hybrid vehicle components supports regional exposure.

Global

Higher input costs in Pavement Technologies reflect broader commodity price pressures.

Counterpoint

What could challenge this read

The narrowed EBITDA outlook could be a warning sign of slowing growth, suggesting a short position.

Key entities

  • company
    Ingevity Corp

    Specialty chemicals producer reporting Q3 results and updated EBITDA guidance.

Read at source← All news

StoryIngevity posts Q3 2026 results with lower sales but higher profit and raises full‑year outlook

Also covered by

3 outlets

Related articles

$NGVTMed

Ingevity (NGVT) Lifted EPS Guidance, Is The Stock Still Cheap?

Ingevity (NGVT) raised its full-year EPS guidance despite lower Q3 sales. The stock has fallen 15.34% in the past week but remains up 25.15% over one year. Analysts estimate fair value at $89, suggesting a 30% undervaluation, though its P/E ratio is higher than industry averages. The company plans $300M in share buybacks by 2027.

finance.yahoo.com
$NGVTHighAI 8/10

Ingevity Q3 Earnings Call Highlights

Ingevity (NGVT) reports Q3 earnings, highlighting growth in hybrid vehicle and filtration markets. CEO Dave Li notes benefits from the hybrid transition and new water treatment contracts. Pavement Technologies sales fell 24% due to divestiture and higher asphalt costs. Advanced Polymer Technologies sales rose 18%. The company narrowed its 2026 adjusted EBITDA outlook to $385M-$395M and expects $1.1B in sales. Ingevity repurchased $39M in shares during Q3.

finance.yahoo.com
$NGVTMed

Ingevity (NGVT) Q3 2026 Earnings Call Transcript

Ingevity (NGVT) reported Q3 2026 sales of $305M, down 8% YoY due to divestitures, but up 2% excluding them. Adjusted EBITDA was $108M, down 2%, with margins expanding to 35.4%. EPS rose 24% to $1.63. The company highlighted growth in filtration and water treatment, secured new contracts, and repurchased $39M in shares. Full-year adjusted EBITDA is expected to be $385M-$395M, with sales around $1.1B and EPS of $5.25-$5.45.

finance.yahoo.com
$NGVTHigh

Ingevity reports third quarter 2026 financial results

Ingevity reported Q3 2026 net sales of $305.1M, down 8% YoY. Net income rose to $51.1M per diluted share. Adjusted EBITDA fell $108M but margin expanded to 35.4%. The company narrowed its full-year adjusted EBITDA outlook to $385M-$395M. CEO Dave Li cited strong Performance Materials but noted challenges in Pavement Technologies. Ingevity (NYSE: NGVT) plans to host an earnings call on November 5, 2026.

stocktitan.net